spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirabet, M.
Right arrow Articles by Franco, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirabet, M.
Right arrow Articles by Franco, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Cell Science, Vol 112, Issue 4 491-502, Copyright © 1999 by Company of Biologists


JOURNAL ARTICLES

Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation

M Mirabet, C Herrera, OJ Cordero, J Mallol, C Lluis and R Franco
Department of Biochemistry and Molecular Biology, Faculty of Chemistry, University of Barcelona, Barcelona, Catalonia, Spain. r.franco@sun.bq.ub.es.

Extracellular adenosine has a key role in the development and function of the cells of the immune system. Many of the adenosine actions seem to be mediated by specific surface receptors positively coupled to adenylate cyclase: A2A and A2B. Despite the fact that A2A receptors (A2ARs) can be easily studied due to the availability of the specific agonist CGS21680, a pharmacological and physiological characterization of adenosine A2B receptors (A2BRs) in lymphocytes has not been possible due to the lack of suitable reagents. Here we report the generation and characterization of a polyclonal antipeptide antibody raised against the third extracellular loop of the A2BR human clone which is useful for immunocytochemical studies. This antibody has permitted the detection of A2BR+ cells in lymphocyte samples isolated from human peripheral blood. The pharmacology of cAMP-producing compounds is consistent with the presence of functional A2BRs but not of A2A receptors in these human cells. The percentage of A2BR-expressing cells was similar in the CD4(+) or CD8(+) T cell subpopulations. Interestingly activation signals delivered by either phytohemagglutinin or anti-T cell receptor/CD3 complex antibodies led to a significant increase in both the percentage of cells expressing the receptor and the intensity of the labeling. These receptors are functional since interleukin-2 production in these cells is reduced by NECA but not by R-PIA or CGS21680. These results show that A2BR expression is regulated in T cell activation and suggest that the role of adenosine in lymphocyte deactivation is mediated by A2BRs.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. L. Kolachala, R. Bajaj, M. Chalasani, and S. V. Sitaraman
Purinergic receptors in gastrointestinal inflammation
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G401 - G410.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Z. H. Nemeth, D. Bleich, B. Csoka, P. Pacher, J. G. Mabley, L. Himer, E. S. Vizi, E. A. Deitch, C. Szabo, B. N. Cronstein, et al.
Adenosine receptor activation ameliorates type 1 diabetes
FASEB J, August 1, 2007; 21(10): 2379 - 2388.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
X. Hua, M. Kovarova, K. D. Chason, M. Nguyen, B. H. Koller, and S. L. Tilley
Enhanced mast cell activation in mice deficient in the A2b adenosine receptor
J. Exp. Med., January 22, 2007; 204(1): 117 - 128.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Pacheco, J. M. Martinez-Navio, M. Lejeune, N. Climent, H. Oliva, J. M. Gatell, T. Gallart, J. Mallol, C. Lluis, and R. Franco
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse
PNAS, July 5, 2005; 102(27): 9583 - 9588.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Gessi, K. Varani, S. Merighi, E. Cattabriga, C. Pancaldi, Y. Szabadkai, R. Rizzuto, K.-N. Klotz, E. Leung, S. Mac Lennan, et al.
Expression, Pharmacological Profile, and Functional Coupling of A2B Receptors in a Recombinant System and in Peripheral Blood Cells Using a Novel Selective Antagonist Radioligand, [3H]MRE 2029-F20
Mol. Pharmacol., June 1, 2005; 67(6): 2137 - 2147.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Lappas, J. M. Rieger, and J. Linden
A2A Adenosine Receptor Induction Inhibits IFN-{gamma} Production in Murine CD4+ T Cells
J. Immunol., January 15, 2005; 174(2): 1073 - 1080.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Zhang, D. M. Conrad, J. J. Butler, C. Zhao, J. Blay, and D. W. Hoskin
Adenosine Acts through A2 Receptors to Inhibit IL-2-Induced Tyrosine Phosphorylation of STAT5 in T Lymphocytes: Role of Cyclic Adenosine 3',5'-Monophosphate and Phosphatases
J. Immunol., July 15, 2004; 173(2): 932 - 944.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Gessi, K. Varani, S. Merighi, E. Cattabriga, A. Avitabile, R. Gavioli, C. Fortini, E. Leung, S. M. Lennan, and P. A. Borea
Expression of A3 Adenosine Receptors in Human Lymphocytes: Up-Regulation in T Cell Activation
Mol. Pharmacol., March 1, 2004; 65(3): 711 - 719.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. F. Agnati, S. Ferre, C. Lluis, R. Franco, and K. Fuxe
Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons
Pharmacol. Rev., September 1, 2003; 55(3): 509 - 550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. J. Salgado, J. Lojo, J. L. Alonso-Lebrero, C. Lluis, R. Franco, O. J. Cordero, and M. Nogueira
A Role for Interleukin-12 in the Regulation of T Cell Plasma Membrane Compartmentation
J. Biol. Chem., June 27, 2003; 278(27): 24849 - 24857.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
O. J. Cordero, F. J. Salgado, C. M. Fernandez-Alonso, C. Herrera, C. Lluis, R. Franco, and M. Nogueira
Cytokines regulate membrane adenosine deaminase on human activated lymphocytes
J. Leukoc. Biol., December 1, 2001; 70(6): 920 - 930.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Majumdar and B. B. Aggarwal
Methotrexate Suppresses NF-{kappa}B Activation Through Inhibition of I{kappa}B{alpha} Phosphorylation and Degradation
J. Immunol., September 1, 2001; 167(5): 2911 - 2920.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Herrera, V. Casadó, F. Ciruela, P. Schofield, J. Mallol, C. Lluis, and R. Franco
Adenosine A2B Receptors Behave as an Alternative Anchoring Protein for Cell Surface Adenosine Deaminase in Lymphocytes and Cultured Cells
Mol. Pharmacol., January 1, 2001; 59(1): 127 - 134.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
S. Sarrió, V. Casadó, M. Escriche, F. Ciruela, J. Mallol, E. I. Canela, C. Lluis, and R. Franco
The Heat Shock Cognate Protein hsc73 Assembles with A1 Adenosine Receptors To Form Functional Modules in the Cell Membrane
Mol. Cell. Biol., July 15, 2000; 20(14): 5164 - 5174.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Herrera, C. Morimoto, J. Blanco, J. Mallol, F. Arenzana, C. Lluis, and R. Franco
Comodulation of CXCR4 and CD26 in Human Lymphocytes
J. Biol. Chem., May 25, 2001; 276(22): 19532 - 19539.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 1999